InBody Co Ltd (041830)

Currency in KRW
59,100
-900(-1.50%)
Delayed Data·
041830 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
58,40060,500
52 wk Range
26,00073,500
Key Statistics
Bid/Ask
58,800.00 / 58,900.00
Prev. Close
60,000
Open
60,000
Day's Range
58,400-60,500
52 wk Range
26,000-73,500
Volume
58.57K
Average Volume (3m)
124.8K
1-Year Change
117.6796%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
041830 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
100,000
Upside
+69.20%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 100,000
(+69.20% Upside)

Earnings

Latest Release
Aug 14, 2026
EPS / Forecast
1,060.00 / --
Revenue / Forecast
69.5B / 67.4B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3,566.10%
Dividend Yield
1.00%
Industry Median 2.24%
Annualized payout
600.00
Paid annually
5-Years Growth
+23.36%
Growth Streak

041830 Income Statement

Compare 041830 to Peers and Sector

Metrics to compare
041830
Peers
Sector
Relationship
P/E Ratio
17.0x7.8x−0.4x
PEG Ratio
0.360.100.00
Price/Book
2.3x0.9x2.6x
Price / LTM Sales
3.0x1.1x3.0x
Upside (Analyst Target)
66.7%42.1%49.0%
Fair Value Upside
Unlock37.2%6.5%Unlock

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.48M18.62%151.81B
Other Institutional Investors
1.81M13.54%110.44B
Public Companies & Retail Investors
9.05M67.84%553.23B
Total
13.35M100.00%815.47B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FMR LLC10.09%1,346,74082,285,814
NAVER Corporation8.59%1,145,87570,012,963

People Also Watch

7,260
073240
-1.22%
124,700
078930
-0.72%
31,600
214150
-1.25%
229,000
018260
-5.57%
55,600
120110
+0.72%

FAQ

What Is the InBody (041830) Stock Price Today?

The InBody stock price today is 59,100 KRW.

What Stock Exchange Does InBody Trade On?

InBody is listed and trades on the KOSDAQ.

What Is the Stock Symbol for InBody?

The stock symbol for InBody is "041830."

Does InBody Pay Dividends? What’s The Current Dividend Yield?

The InBody dividend yield is 0.98%.

What Is the InBody Market Cap?

As of today, InBody market cap is 800.79B KRW.

What Is InBody's Earnings Per Share (TTM)?

The InBody EPS (TTM) is 3,566.

When Is the Next InBody Earnings Date?

InBody will release its next earnings report on Nov 16, 2026.

From a Technical Analysis Perspective, Is 041830 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has InBody Stock Split?

InBody has split 3 times.

How Many Employees Does InBody Have?

InBody has 285 employees.

What is the current trading status of InBody (041830)?

As of Sep 08, 2026, InBody (041830) is trading at a price of 59,100 KRW, with a previous close of 60,000 KRW. The stock has fluctuated within a day range of 58,400 KRW to 60,500 KRW, while its 52-week range spans from 26,000 KRW to 73,500 KRW.

What Is InBody (041830) Price Target According to Analysts?

The average 12-month price target for InBody is 100,000 KRW, with a high estimate of 100000 KRW and a low estimate of 100000 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +69.20% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.